AM

Asirrajanayagam Masillamoney

Active Director Director DIN 05166870
DIN 05166870 First appointment Feb 2012 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Asirrajanayagam Masillamoney

Data last updated:

Asirrajanayagam Masillamoney is a Director at Biorhythms Health Caare Private Limited (since 2012). The company operates in Pharma.

DIN 05166870
Primary Designation Director
Industry Pharma
First Appointment 14 Feb 2012
Oldest Company Age 14 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Feb 20122012Active

Board colleagues of Asirrajanayagam Masillamoney

NameDINCompanyDesignation
Paul Vasanthakumar Sam Gnana Nimalan05166826Biorhythms Health Caare Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Biorhythms Health Caare Private Limited
Premium access

Shareholding and investment profile for Asirrajanayagam Masillamoney

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asirrajanayagam Masillamoney

Asirrajanayagam Masillamoney currently holds 1 directorship: Biorhythms Health Caare Private Limited (Director, since 14 Feb 2012).

Asirrajanayagam Masillamoney was first appointed on 14 Feb 2012 as Director at Biorhythms Health Caare Private Limited.

The current boards of Asirrajanayagam Masillamoney's companies include Paul Vasanthakumar Sam Gnana Nimalan (Biorhythms Health Caare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available